Long-term recurrence-free survival in a patient with pancreatic carcinosarcoma: a case report with a literature review.
Here, we presented a case of carcinosarcoma of the pancreas in a 53-year-old woman. The carcinosarcoma was in the head of pancreas. She underwent a pancreaticoduodenectomy. The tumor was grossly yellowish-whitish. Histologic evaluation of the tumor revealed 2 elements separated from each other. One component was conventional pancreatic ductal adenocarcinoma, and the other component showed sarcomatous growth pattern composed of pleomorphic spindle cells. Immunohistochemically, the adenocarcinoma component was reactive for antibodies to cytokeratin 18 and epithelial membrane antigen. The sarcomatous component was reactive for smooth muscle antibody. These findings led to a diagnosis of pancreatic carcinosarcoma. The patient was treated with gemcitabine, adriamycin, and cisplatin after the operation. Although previously reported patients with pancreatic carcinosarcoma showed a very poor outcome, this patient has remained free of recurrence for 20 months, which is the longest recurrence-free survival time recorded for this type of cancer. This treatment plan may be a feasible option.
Divsion of Abdominal Cancer, Cancer Center of West China Hospital, SiChuan University, No 37, GuoXue Road, Chengdu, Sichuan Province 610041, China. 502402227@qq.com
Wen-Yan
WY
Zhu
Tai-Guo
TG
Liu
Hong
H
Zhu
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002296:Carcinosarcoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D018572:Disease-Free Survival; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D016577:Pancreaticoduodenectomy; D012008:Recurrence; D000093542:Gemcitabine
D003841:Deoxycytidine; D004317:Doxorubicin; D002945:Cisplatin; D000093542:Gemcitabine
Mod Pathol. 2000 Jan;13(1):86-91
10658914
J Submicrosc Cytol Pathol. 2003 Oct;35(4):343-9
15137676
Pancreatology. 2005;5(2-3):279-84
15849490
Pancreas. 1997 Aug;15(2):201-8
9260206
Am Surg. 2006 Apr;72(4):351-5
16676863
Eur J Cancer Care (Engl). 2010 Jan 1;19(1):118-23
19486125
Pathol Int. 2008 Oct;58(10):672-7
18801090
JOP. 2008 Jan 08;9(1):50-5
18182744
Surgery. 1994 Jan;115(1):132-7
8284754
Pancreas. 2005 Oct;31(3):291-2
16163064